BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8928064)

  • 1. [Flow cytometry in the determination of DNA aneuploidy in patients with acute leukemias].
    Shmarov DA; Kuchma IuM; Miterev GIu; Kozinets GI
    Ter Arkh; 1996; 68(7):11-4. PubMed ID: 8928064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of FCM-DNA measurement in detecting minimal residual disease in leukemia.
    Zhang RX; Yao EG
    Chin Med J (Engl); 1990 Oct; 103(10):826-30. PubMed ID: 2125256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aneuploidy as a marker of minimal residual disease in leukemia.
    Walle AJ; Niedermayer W
    Cancer Detect Prev; 1985; 8(1-2):303-15. PubMed ID: 4064049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A prognostic factor in childhood acute lymphoblastic leukemia: implication of cellular DNA contents. Children's Cancer and Leukemia Study Group].
    Katano N; Tsurusawa M; Kawai S; Fujimoto T
    Rinsho Ketsueki; 1989 Jul; 30(7):943-50. PubMed ID: 2810797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of blast cell DNA content for prognosis of childhood acute lymphoblastic leukemia.
    Starý J; Hrodek O; Hausner P; Petráková A; Goetz P; Kreuger A
    Neoplasma; 1990; 37(3):293-9. PubMed ID: 2370916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of DNA aneuploidy as a tumor marker].
    Takamoto S
    Gan To Kagaku Ryoho; 1989 Jul; 16(7):2329-37. PubMed ID: 2751314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA aneuploidy in acute myeloblastic leukemia is associated with a high expression of lymphoid markers.
    Vidriales MB; Orfao A; López-Berges MC; González M; López-Macedo A; Ciudad J; López A; Cañizo MC; Garcia MA; San Miguel JF
    Cytometry; 1995 Mar; 22(1):22-5. PubMed ID: 7587729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [DNA aneuploidy in childhood acute leukemia. Children's Cancer and Leukemia Study Group].
    Tsurusawa M; Katano N; Kawai S; Fujimotn T
    Rinsho Ketsueki; 1985 Oct; 26(10):1614-20. PubMed ID: 4094078
    [No Abstract]   [Full Text] [Related]  

  • 9. Flow cytometric evaluation of proliferative activity and ploidy in myelodysplastic syndromes and acute leukemias.
    Riccardi A; Montecucco CM; Danova M; Ucci G; Mazzini G; Giordano PA; Pasquali F
    Basic Appl Histochem; 1986; 30(2):181-92. PubMed ID: 2427061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of minimal residual disease in unselected patients with acute myeloid leukemia using multiparameter flow cytometry for definition of leukemia-associated immunophenotypes and determination of their frequencies in normal bone marrow.
    Kern W; Danhauser-Riedl S; Ratei R; Schnittger S; Schoch C; Kolb HJ; Ludwig WD; Hiddemann W; Haferlach T
    Haematologica; 2003 Jun; 88(6):646-53. PubMed ID: 12801840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a flow cytometric method to determine DNA ploidy of oesophageal cancer cells obtained by forceps biopsy samples during oesophago-gastro-duodenoscopy.
    Rickes S; Hauptmann S; Flath B; Abbenseth R; Zwiebel FM; Possinger K
    Onkologie; 2003 Feb; 26(1):32-7. PubMed ID: 12624515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Various aspects of bone marrow cell proliferation in acute leukemia].
    Shmarov DA; Kuchma IuM; Kozinets GI
    Ter Arkh; 2001; 73(12):73-7. PubMed ID: 11858117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric DNA quantification in immunophenotyped cells as a sensitive method for determination of aneuploid multiple myeloma cells in peripheral blood stem cell harvests and bone marrow after therapy.
    Nowak R; Oelschlägel U; Range U; Bergmann S; Bornhäuser M; Hölig C; Schuler U; Krebs U; Günther H; Kroschinsky F; Ehninger G
    Bone Marrow Transplant; 1999 May; 23(9):895-900. PubMed ID: 10338044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of hematologic malignancies by flow cytometry.
    Barlogie B; Latreille J; Freireich EJ; Fu CT; Mellard D; Meistrich M; Andreeff M
    Blood Cells; 1980; 6(4):719-44. PubMed ID: 7008871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of early marrow response in childhood aneuploid acute lymphoblastic leukemia: flow cytometric DNA analysis versus standard morphology.
    Finn LS; Hawkins DS; Rutledge JC; Patterson K
    Pediatr Dev Pathol; 2004; 7(1):39-47. PubMed ID: 15255034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of minimal residual disease in patients with acute myeloid leukemia].
    Gal'tseva IV; Savchenko VG; Kulikov SM; Parovichnikova EN; Miterev GIu; Maslova ER; Isaev VG
    Ter Arkh; 2003; 75(7):8-14. PubMed ID: 12934474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of minimal residual disease in B lineage acute lymphoblastic leukemia by 4-color flow cytometry].
    Liu YR; Wang H; Chang Y; Cheng YF; Fu JY; Zhang LP; Liu GL; Chen SS
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):327-31. PubMed ID: 16185473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition of central nervous system leukemia by flow cytometry.
    Redner A; Andreeff M; Miller DR; Steinherz P; Melamed M
    Cytometry; 1984 Nov; 5(6):614-8. PubMed ID: 6596184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative chromosome findings and DNA determinations in acute leukemia].
    Orywall D; Müller D
    Arztl Forsch; 1971 Aug; 25(8):268-71. PubMed ID: 5284299
    [No Abstract]   [Full Text] [Related]  

  • 20. [Flow cytometric analysis of cellular DNA content in childhood acute leukemia: prognostic implication of proliferative fraction (S-phase) of leukemic blasts].
    Katano N; Tsurusawa M; Niwa M; Kawai S; Fujimoto T
    Rinsho Ketsueki; 1987 Nov; 28(11):1971-7. PubMed ID: 3446868
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.